Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
about
Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for ManagementMonogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever.Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.Efficacy of anakinra in a patient with systemic amyloidosis presented with amyloidoma.
P2860
Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Anti-interleukin 1 treatment i ...... ith autoinflammatory diseases.
@en
Anti-interleukin 1 treatment i ...... ith autoinflammatory diseases.
@nl
type
label
Anti-interleukin 1 treatment i ...... ith autoinflammatory diseases.
@en
Anti-interleukin 1 treatment i ...... ith autoinflammatory diseases.
@nl
prefLabel
Anti-interleukin 1 treatment i ...... ith autoinflammatory diseases.
@en
Anti-interleukin 1 treatment i ...... ith autoinflammatory diseases.
@nl
P2093
P2860
P1433
P1476
Anti-interleukin 1 treatment i ...... with autoinflammatory diseases
@en
P2093
Diclehan Orhan
Nesrin Besbas
Rezan Topaloglu
P2860
P2888
P304
P356
10.1007/S00467-015-3249-5
P50
P577
2015-11-12T00:00:00Z